GlassScriptPhysician profile
Jennifer Lynn Midtlien
NPI 1639489545
$6,271.18
in general payments reported to CMS, 2019-2025
31 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 87% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,607 · 2022: $893 · 2023: $1,374 · 2024: $1,084 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,590 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,589.80 |
| Education | $181.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,267.23 | 2021-2025 | |
| Epi Health, LLC | $1,016.70 | 2021 | |
| Janssen Biotech, INC. | $441.77 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Lilly USA, LLC | $336.08 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $313.18 | 2023-2025 | |
| Incyte Corporation | $275.31 | 2021-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $258.45 | 2022-2025 | Sotyktu |
| Ucb, INC. | $245.16 | 2021-2025 | Bimzelx, Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.87 | 2022-2025 | Spevigo, Cyltezo |
| Genzyme Corporation | $231.56 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $229.38 | 2021-2024 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $216.31 | 2021-2025 | Nemluvio, Aklief, Epsolay |
| Leo Pharma INC. | $189.02 | 2021-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $178.97 | 2023-2025 | Zoryve |
| Janssen Scientific Affairs, LLC | $122.69 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $94.44 | 2024-2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $89.49 | 2022-2024 | Winlevi, Absorica Ld |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $88.46 | 2021-2024 | Cabtreo, Arazlo |
| Amgen INC. | $68.99 | 2023-2025 | Otezla, Otezla |
| Dermavant Sciences, INC. | $68.45 | 2023-2024 | Vtama |
| Pfizer INC. | $45.48 | 2023-2024 | |
| Almirall LLC | $44.51 | 2021-2022 | |
| Medimetriks Pharmaceuticals, INC. | $43.70 | 2023 | Neo-Synalar |
| Vyne Pharmaceuticals INC. | $38.02 | 2021 | |
| Mayne Pharma Commercial LLC | $28.82 | 2024-2025 | |
| Biofrontera INC. | $21.32 | 2025 | Ameluz |
| Krystal Biotech INC | $18.94 | 2023 | Vyjuvek |
| Paratek Pharmaceuticals, INC. | $18.92 | 2025 | Nuzyra |
| Lnhc, INC | $17.15 | 2025 | Zelsuvmi |
| Sandoz INC. | $14.93 | 2024 | Hyrimoz |
| Dermira, INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Midtlien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.